Tag Archives: The Burden Of Influenza B And Age-Specific Benefit Of Qiv Over Tiv

The Burden Of Influenza B And Age-Specific Benefit Of Qiv Over Tiv

THE BURDEN OF INFLUENZA B AND AGE-SPECIFIC BENEFIT OF QIV OVER TIV Abstract Background To inform national healthcare authorities whether quadrivalent influenza vaccines (QIVs) provide better value for money than trivalent influenza vaccines (TIVs), we assessed the cost-effectiveness of TIV and QIV in low-and-middle income communities based in South Africa …

Read More »